EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Obtaining New Candidate Peptides for Biological Anticancer Drugs from Enzymatic Hydrolysis of Human and Bovine Hemoglobin

Ahlam Outman, Mohamed Bouhrim, Codjo Hountondji, Omar M Noman iD, Ali S Alqahtani iD, Bernard Gressier, Naïma Nedjar, Bruno Eto

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242015383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ahlam Outman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratories TBC, Laboratory of Pharmacology, Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Lille, 3, rue du Professeur …. Hauptthemen laut MEDLINE: Anti-Infective Agents, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Researchers, King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enzymatic hydrolysis of bovine and human hemoglobin generates a diversity of bioactive peptides, mainly recognized for their antimicrobial properties. However, antimicrobial peptides stand out for their ability to specifically target cancer cells while preserving rapidly proliferating healthy cells. This study focuses on the production of bioactive peptides from hemoglobin and evaluates their anticancer potential using two distinct approaches. The first approach is based on the use of a rapid screening method aimed at blocking host cell protein synthesis to evaluate candidate anticancer peptides, using Lepidium sativum seed germination as an indicator. The results show that: (1) The degree of hydrolysis (DH) significantly influences the production of bioactive peptides. DH levels of 3 to 10% produce a considerably stronger inhibition of radicle growth than DH 0 (the native form of hemoglobin), with an intensity three to four times greater. (2) Certain peptide fractions of bovine hemoglobin have a higher activity than those of human hemoglobin. (3) The structural characteristics of peptides (random coil or alpha helix) play a crucial role in the biological effects observed. (4) The α137–141 peptide, the target of the study, was the most active of the fractions obtained from bovine hemoglobin (IC50 = 29 ± 1 µg/mL) and human hemoglobin (IC50 = 48 ± 2 µg/mL), proving to be 10 to 15 times more potent than the other hemoglobin fractions, attributed to its strong antimicrobial potential. The second approach to assessing anticancer activity is based on the preliminary in vitro analysis of hydrolysates and their peptide fractions, with a focus on the eL42 protein. This protein is of major interest due to its overexpression in all cancer cells, making it an attractive potential target for the development of anticancer molecules. With this in mind, astudy was undertaken using a method for labeling formylase (formyl-methionyl-tRNA transformylase (FMTS)) with oxidized tRNA. This approach was chosen because of the similarities in the interaction between formylase and the eL42 protein with oxidized tRNA. The results obtained not only confirmed the previous conclusions but also reinforced the hypothesis that the inhibition of protein synthesis plays a key role in the anticancer mechanism of these peptides. Indeed, the data suggest that samples containing α137–141 peptide (NKT) and total hydrolysates may have modulatory effects on the interaction between FMTS and oxidized tRNA. This observation highlights the possibility that the latter could influence molecular binding mechanisms, potentially resulting in a competitive situation where the ability of substrate tRNA to bind efficiently to ribosomal protein is compromised in their presence. Ultimately, these results suggest the feasibility of obtaining candidate peptides for biological anticancer drugs from both human and bovine hemoglobin sources. These scientific advances show new hope in the fight against cancer, which affects a large number of people around the world.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsAntineoplastic AgentsHumansHydrolysisPeptidesHemoglobinsRNA, TransferProtein Hydrolysates

Stichwörter der Autor:innen

bioactive peptidesbovine hemoglobin bovineenzymatic hydrolysishuman hemoglobinmedicine candidate anticancerscreening

Substanzen

PeptidesAnti-Infective AgentsHemoglobinsAntineoplastic AgentsRNA, TransferProtein Hydrolysates

Autor:innen und Institutionen

  • Laboratories TBC, Laboratory of Pharmacology, Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Lille, 3, rue du Professeur Laguesse, B.P. 83, 59000 Lille, France.
  • UMR Transfrontalière BioEcoAgro N_1158, Institut Charles Viollette, National Research Institute for Agriculture, Food and the Environment-Université Liège, UPJV, YNCREA, Université Artois, Université Littoral Côte d'Opa…
  • Laboratoire Enzymologie de l'ARN (UR6-UPMC), Université Paris Sorbonne, 75252 Paris, France.
  • Department of Pharmacognosy, College of Pharmacy, King Saudi University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Laboratory of Pharmacology, Pharmacokinetics, and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, University of Lille, 3, rue du Professeur Laguesse, B.P. 83, 59000 Lille, France.

ORCID-Profile: Omar M Noman, Ali S Alqahtani

Förderung

  • Researchers, King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Outman, A., Bouhrim, M., Hountondji, C., Noman, O. M., Alqahtani, A. S., Gressier, B., Nedjar, N., & Eto, B. (2023). Obtaining New Candidate Peptides for Biological Anticancer Drugs from Enzymatic Hydrolysis of Human and Bovine Hemoglobin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015383

Vancouver

Outman A, Bouhrim M, Hountondji C, Noman OM, Alqahtani AS, Gressier B, et al. Obtaining New Candidate Peptides for Biological Anticancer Drugs from Enzymatic Hydrolysis of Human and Bovine Hemoglobin. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015383

BibTeX
@article{Outman2023,
  author = {Outman, Ahlam and Bouhrim, Mohamed and Hountondji, Codjo and Noman, Omar M and Alqahtani, Ali S and Gressier, Bernard and Nedjar, Naïma and Eto, Bruno},
  title = {Obtaining New Candidate Peptides for Biological Anticancer Drugs from Enzymatic Hydrolysis of Human and Bovine Hemoglobin},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242015383}
}
Kostenlos starten →